Differential effects of 17beta-estradiol, conjugated equine estrogen, and raloxifene on mRNA expression, aggregation, and secretion in platelets. - Wikidata - awgldk - TriplyDB

Differential effects of 17beta-estradiol, conjugated equine estrogen, and raloxifene on mRNA expression, aggregation, and secretion in platelets.

Differential effects of 17beta-estradiol, conjugated equine estrogen, and raloxifene on mRNA expression, aggregation, and secretion in platelets.

http://www.wikidata.org/entity/Q45226665

about

Circulating microparticles and endogenous estrogen in newly menopausal women.Aggregation and microparticle production through toll-like receptor 4 activation in platelets from recently menopausal women.Ovariectomy differential influence on some hemostatic markers of mice and rats.Hormone therapy and risk of cardiovascular outcomes and mortality in women treated with statins.Selective estrogen receptor modulation influences atherosclerotic plaque composition in a rabbit menopause model Sex, stroke, and inflammation: the potential for estrogen-mediated immunoprotection in stroke.Longitudinal effects of menopausal hormone treatments on platelet characteristics and cell-derived microvesicles.Testosterone alters maternal vascular adaptations: role of the endothelial NO system.Sex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause.Selective estrogen receptor modulators and risk for coronary heart disease.Ageing, oestrogen, platelets and thrombotic risk.Vascular actions of estrogens: functional implications.17Beta-estradiol increases basal but not bradykinin-stimulated release of active t-PA in young postmenopausal women.Differential effects of oral and transdermal menopausal hormone therapy on prostacyclin and thromboxane in platelets.Primary prevention of cardiovascular disease with HRT.Estrogenic regulation of tissue factor and tissue factor pathway inhibitor in platelets.Platelet characteristics change with aging: role of estrogen receptor beta.17Beta-oestradiol partially attenuates the inhibition of nitric oxide synthase-3 by advanced glycation end-products in human platelets.Bioidentical menopausal hormone therapy: registered hormones (non-oral estradiol ± progesterone) are optimal.

P2860

Q34476755-5567FCE7-4D56-408A-A1DD-08B04B039562 Q34491825-DF7269CA-0DB0-46CA-A6F8-3925230756E9 Q35086559-02A3592F-2F8C-4F77-ACCE-AC27D57B1F34 Q35751419-2ABC3240-FC41-4D98-AEE2-02DDF57EEA33 Q36071309-1D73573A-2500-4E91-89BD-583384BB6303 Q36185871-6F3E47D7-CEF0-448A-880A-5D5764A65C0A Q36519047-9AD867D0-B959-40DA-9C28-3AA99C34CB7B Q36682542-0F3D8F0D-7035-4D5D-8AC3-BF3D24EE018C Q36758718-91009992-04B4-41AD-9A3D-482AB11A7162 Q36799439-68DA43C2-B667-41FE-851E-D09AA9549DBD Q36864696-905FFF98-105E-47B1-8037-509AB4566E4D Q37088243-7EF23F94-700C-481C-9034-CA574CA5757A Q37170186-E863F29C-EFD6-4E85-9E64-DABDBF93AEC1 Q37727922-3DE61285-F9C1-4814-BC16-EC4C766F189F Q37968650-90DBD660-D6E1-47A9-9FC2-27B5EC0270FC Q42480099-989DFE10-619E-46F8-BEE2-283B9D6A0EFE Q42482148-8511AAA1-25D0-4E1D-A8A8-A997B5518C1A Q51740951-FE30EFC1-0BA0-4959-9806-7970B961D302 Q55060038-CA79B029-47F6-46C4-B11C-9302AF6E2337

P2860

Differential effects of 17beta-estradiol, conjugated equine estrogen, and raloxifene on mRNA expression, aggregation, and secretion in platelets.

http://www.wikidata.org/entity/Q45226665

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Differential effects of 17beta ...... n, and secretion in platelets.

@en

Differential effects of 17beta ...... n, and secretion in platelets.

@nl

type

label

Differential effects of 17beta ...... n, and secretion in platelets.

@en

Differential effects of 17beta ...... n, and secretion in platelets.

@nl

prefLabel

Differential effects of 17beta ...... n, and secretion in platelets.

@en

Differential effects of 17beta ...... n, and secretion in platelets.

@nl

P1433

Q45226665-B29EC53E-CECA-4AC8-9756-BF05D25F1159

P1476

Q45226665-DB64EEF1-1557-4BD7-A25C-396776F3E2BB

P2093

Q45226665-0951B639-8979-448C-AEC7-EC2DD4FB5E2F

Q45226665-12A5A4ED-711B-47C4-A91A-3B1BC7F1BBE0

Q45226665-1E5DAB93-863B-428A-A746-18DE6CED1390

Q45226665-3B27CD8A-5803-466F-9985-F2EA156DEF8D

Q45226665-61403374-0BB5-40FD-A245-B2CC61626C21

Q45226665-74BACBF2-DC95-457B-9DC9-E706BD644EBB

Q45226665-8A047103-E8E3-4FA8-9401-D2A7FB95735C

Q45226665-C4F1081B-0939-4073-AB9D-5BC4AFFAEA6F

P2860

Q45226665-2F200B7D-863C-462F-BD0A-2E81E04D3FD2

Q45226665-30FD2108-FBD7-4A1F-957F-F6B42394AE01

Q45226665-3612E6C4-EBB4-422D-AAF8-9008E550C915

Q45226665-3CC28D89-E291-4AFB-B34F-71353EBAAD7B

Q45226665-48F7087C-5815-44E6-AC2A-ED4B128845B0

Q45226665-551C5DEC-2349-4F0E-AE48-0690EDD2A2F3

Q45226665-5FABAFE3-1904-4F3B-A0E8-BAA5C04AAA02

Q45226665-73F3202B-DA17-4639-8ACA-C7610E5B2D5B

Q45226665-8294C289-5210-40F2-A7DF-643B91B57C03

Q45226665-8338AB29-5C9F-40B2-9D1F-5A7422FB5420

P304

Q45226665-542DB2EE-EC35-4847-B2FB-6ACFD2F86E5A

P31

Q45226665-428CBB04-261C-4632-8231-757F35217154

P356

Q45226665-2CCEE8C0-1644-4306-9BE2-3BAFCB4B4099

P433

Q45226665-44718F63-A59E-4137-B330-92D7CD9BB70C

P478

Q45226665-12543174-48C3-4F1D-86A6-E4954606371C

P577

Q45226665-88C84EF5-2BE1-4931-A2F5-1A745DC51DF2

P5875

Q45226665-59F86735-F569-428C-B5DD-C4ACDAB5C635

P698

Q45226665-90D45217-A9EB-482B-85EC-EA4EF61590C1

P356

AJPHEART.01108.2004

P1433

American Journal of Physiology - Heart and Circulatory Physiology

P1476

Differential effects of 17beta ...... n, and secretion in platelets.

@en

P2093

Hiroya Okano

http://www.w3.org/2001/XMLSchema#string

Margarita P Bracamonte

http://www.w3.org/2001/XMLSchema#string

Muthuvel Jayachandran

http://www.w3.org/2001/XMLSchema#string

Peter LaBreche

http://www.w3.org/2001/XMLSchema#string

Rajarshi Mukherjee

http://www.w3.org/2001/XMLSchema#string

Thomas Steinkamp

http://www.w3.org/2001/XMLSchema#string

Virginia M Miller

http://www.w3.org/2001/XMLSchema#string

Whyte G Owen

http://www.w3.org/2001/XMLSchema#string

P2860

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

Proplatelet formation of megakaryocytes is triggered by autocrine-synthesized estradiol.

Adenine nucleotides and 5-hydroxytryptamine released by aggregating platelets inhibit adrenergic neurotransmission in canine coronary artery.

Aggregating human platelets cause direct contraction and endothelium-dependent relaxation of isolated canine coronary arteries. Role of serotonin, thromboxane A2, and adenine nucleotides.

Estrogen modulation of endothelial nitric oxide synthase.

Estrogen inhibits the response-to-injury in a mouse carotid artery model.

Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens.

Ovariectomy upregulates expression of estrogen receptors, NOS, and HSPs in porcine platelets.

The estrogen receptor is present in human megakaryocytes.

P304

H2355-62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPHEART.01108.2004

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

288

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8077183

http://www.w3.org/2001/XMLSchema#string

P698

15653758

http://www.w3.org/2001/XMLSchema#string